News

The 2nd CRISPR Medicine Conference 2025

The 2nd CRISPR Medicine Conference | 7-11 April 2025 | Copenhagen, Denmark

- Jun. 26, 2024
News

Stay updated here

Tags

HashtagEvents

CLINICAL TRIALS
Multiple Sclerosis, (NCT07008378)
Sponsors:
Genentech, Inc.
Indicator
IND Enabling
Phase I
Phase II
Phase III
Hemophilia B, (NCT06611436)
Sponsors:
Be Biopharma
IndicatorIndicator
IND Enabling
Phase I
Phase II
Phase III
Heterozygous familial hypercholesterolemia, (ChiCTR2400093099)
Sponsors:
Primary sponsor: The First Affiliated Hospital of Bengbu Medical College Primary sponsor's address: 287 Changhuai Road, Longzihu District, Bengbu, Anhui, China Secondary sponsor: Country: China Province: Anhui City: Bengbu Institution hospital: The First Affiliated Hospital of Bengbu Medical College Address: 287 Changhuai Road, Longzihu District
IND Enabling
Phase I
Phase II
Phase III
View all clinical trials
close
Search CRISPR Medicine